Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

Prognostic Value of PRAME Activity in Tumor Cells of Follicular Lymphoma

Aim. To set survival parameters for follicular lymphoma (FL) patients with different PRAME expression levels in tumor cells. Materials & Methods. The study was conducted on samples of lymph nodes, blood, and bone marrow of 34 patients with newly diagnosed FL. PRAME expression levels were measur...

Full description

Bibliographic Details
Main Authors:	VA Misyurin, AE Misyurina, SK Kravchenko, NA Lyzhko, YuP Finashutina, NN Kasatkina, DS Mar’in, ES Nesterova, NN Sharkunov, MA Baryshnikova, AV Misyurin
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2019-03-01
Series:	Kliničeskaâ onkogematologiâ
Subjects:	prame gene follicular lymphoma
Online Access:	http://bloodjournal.ru/wp-content/uploads/2019/03/7-1.pdf

Similar Items

Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders
by: EA Penskaya, et al.
Published: (2018-12-01)

Clinical Significance of the PRAME Gene Expression in Oncohematological Diseases
by: VA Misyurin
Published: (2018-01-01)

Theory and Practice of Immunotherapy Directed against the PRAME Antigen
by: VA Misyurin
Published: (2018-04-01)

Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib
by: V. A. Misyurin, et al.
Published: (2019-01-01)

PRAME gene expression profile in medulloblastoma
by: Tânia Maria Vulcani-Freitas, et al.
Published: (2011-02-01)

Expression of PRAME gene in multiple myeloma
by: I В Abramenko, et al.
Published: (2004-07-01)

Meme kanserinde PRAME (preferentially expressed antigen of melanoma) ekspresyonunun prognostik önemi
by: Kubilay Dalcı, et al.
Published: (2020-09-01)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
by: Yusuke Muto, et al.
Published: (2020-09-01)

The Challenge of Melanocytic Lesions in Pediatric Patients: Clinical-Pathological Findings and the Diagnostic Value of PRAME
by: Giuseppina Rosaria Umano, et al.
Published: (2021-06-01)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
by: Sietse J Luk, et al.
Published: (2018-12-01)

Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas
by: Maximilian Gassenmaier, et al.
Published: (2021-07-01)

In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate
by: Mortaza Taheri-Anganeh, et al.
Published: (2021-01-01)

Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit
by: Chang, S.E, et al.
Published: (2022)

Tyrosine Kinase Inhibitor Resistance in Patients with Chronic Myeloid Leukemia: A 10-Year Study of BCR-ABL Gene Mutation Profile in Russia (2006–2016)
by: VV Tikhonova, et al.
Published: (2018-07-01)

Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
by: Hanzhang Zhu, et al.
Published: (2018-02-01)

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi, et al.
Published: (2019-07-01)

Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry
by: Jwala Priyadarsini Sivaccumar, et al.
Published: (2021-03-01)

Diagnosis of Pediatric-Type Follicular Lymphoma in Young Adults (Own Data)
by: AM Kovrigina, et al.
Published: (2017-01-01)

Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
by: Koon H Lee, et al.
Published: (2020-01-01)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
by: Ghaneya Al-Khadairi, et al.
Published: (2019-01-01)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
by: Markus Albertsmeier, et al.
Published: (2020-12-01)

T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
by: Braun, M., et al.
Published: (2022)

Perfil de expressão dos genes MYC, MYCN, TERT, ASPM e PRAME em Meduloblastoma
by: Vulcani-Freitas, Tânia Maria [UNIFESP]
Published: (2015)

The Comparison of De Novo Grade 3 Follicular Lymphoma and Transformed Grade 3 Follicular Lymphoma: Own Data
by: LV Plastinina, et al.
Published: (2017-10-01)

Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression
by: LA Kesaeva, et al.
Published: (2018-10-01)

Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients
by: Arumugam, M., et al.
Published: (2022)

Characteristics of Hematopoiesis in Follicular Lymphoma Patients
by: MA Frenkel, et al.
Published: (2019-12-01)

A rare face of follicular lymphoma: reverse variant of follicular lymphoma
by: Ninu Maskey, et al.
Published: (2020-04-01)

TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas
by: AE Misyurina, et al.
Published: (2019-05-01)

Follicular variant of peripheral T-cell lymphoma
by: Archana Lakshmanan, et al.
Published: (2017-01-01)

Follicular lymphoma
by: Lali G. Babicheva, et al.
Published: (2020-06-01)

Regulação da expressão de SH3BGRL2, D53, PRAME, DAP12 e calcineurina A beta por BCR-ABL e consequências biológicas dessa regulação na LMC.
by: Daniel Diniz de Carvalho
Published: (2009)

Regulação da expressão de SH3BGRL2, D53, PRAME, DAP12 e calcineurina A beta por BCR-ABL e consequências biológicas dessa regulação na LMC.
by: Carvalho, Daniel Diniz de
Published: (2009)

Follicular vitiligo: the present clinical status
by: Khalifa E. Sharquie, et al.
Published: (2016-04-01)

Loss of CD20 Expression in Follicular Lymphoma after Program Anti-Tumor Therapy Including Rituximab: Literature Data and Case Report
by: OM Volodina, et al.
Published: (2017-04-01)

Primary epiglottic follicular variant of peripheral T-cell lymphoma
by: Jienan Kong, et al.
Published: (2019-01-01)

Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease
by: E S Nesterova, et al.
Published: (2017-07-01)

Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma–a Meta-Analysis
by: Martyna Borowczyk, et al.
Published: (2021-02-01)

Autologous stem cells transplantation in the first remission of follicular lymphoma as "rescue therapy" in patients with unfavorable prognosis factors. The first prospective study results
by: E S Nesterova, et al.
Published: (2016-12-01)

FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
by: Alessia Castellino, et al.
Published: (2017-01-01)